chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vertigo, ringing in ears, plugged ears.  Same thing happened happened last year with fluzone.
Breakthrough case admission after 2 vaccines Pfizer 4/27/21 Lot# Ew0176;  Pfizer 5/17/21 Lot# Ew0183
On day of immunizations, patient developed extreme fussiness and cried for 2 days. The crying was inconsolable. Mother reports the child will not take bottle since episode (breast feeding).
Fever, deep chills, shakes, muscle aches over my entire body, even my hair hurts, a slight dry cough. Very extreme fatigue and I am not able to sleep well which is causing me to be really tired. This started as a pain in my arm couple of hours after vaccination and by the next morning all these symptoms  started. These symptoms are causing me to not be able to function. I have no appetite.  I have spoke to my doctor on the phone  Monday evening 02/08/2021, doctor said to drink fluids and take ibuprofen and it will probably go away.
07may90 pt vax hepta B. following exposure to saliva from a state hosp pt. 08may90 pt devel shakiness, severe headache and right sided tremors that lasted 60-90 sec.
PT to MD office for c/o prolonged cough. MD RX antibiotic amoxil & Nasonex, Sudafed for r/o nasal/sinus infection. Ordered chickenpox vaccine at this visit. PT came down with full blown chicken pox blisters on trunk, head, face, genitalia - 8 days later. Verified by MD visit Nov. 02. > 102 deg F x 2-3 days in afternoon - eve.
Patient reported "painful arm and how elbow to shoulder" during the first week. During this same week, "2 incidents of severe facial pain that lasted 10 minutes each. Left side of face (front) like aware then disappeared." During the 2nd and 3rd week, "Went out of state. It hit me 5 days of intense pain on left side of face (trigeminal neuralgia) so severe I could only lay in bed curled up in fetal position every 2 hours." She stated "I took pain medication (NORCO) and Gabapentin...NORCO available for migraines appearing only to RIGHT side of face and head last 40 years for migraines. This was NOT a migraine. She takes Gabapentin for idiopathic neuropathy but has since discontinued. During the 4th and 5th weeks "more incidents but transient, lasting a few minutes to 1 hour...took NORCO." During the 6th week," small transient pain in left side but most gone. **This was written by patient on paper**.
Pt had a hard knot and she doubled over in pain. Whole arm and shoulder hurt with an egg size knot.
Phlegm; Bronchitis; Head cold; This spontaneous case was reported by a non-health professional and describes the occurrence of NASOPHARYNGITIS (Head cold), PRODUCTIVE COUGH (Phlegm) and BRONCHITIS (Bronchitis) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Penicillin allergy and Drug allergy.   On 01-Jan-2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Mar-2022, the patient experienced NASOPHARYNGITIS (Head cold) and BRONCHITIS (Bronchitis). On an unknown date, the patient experienced PRODUCTIVE COUGH (Phlegm). At the time of the report, NASOPHARYNGITIS (Head cold) and BRONCHITIS (Bronchitis) had resolved and PRODUCTIVE COUGH (Phlegm) outcome was unknown.            Formulation of Humira was reported as Solution for injection in pre-filled pen.  No concomitant medication was reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Primary reporter did not have the lot number information, because the packaging. was discarded.  No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Shot at 2:00 pm. Chills at 7:00 pm.  Violent shaking from the chills that hurt my back & chest.  Headache sore throat, dizzy
Felt diffuse chest pressure throughout the chest; This spontaneous case was reported by an other health care professional and describes the occurrence of CHEST DISCOMFORT (Felt diffuse chest pressure throughout the chest) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced CHEST DISCOMFORT (Felt diffuse chest pressure throughout the chest). On 14-Aug-2021, CHEST DISCOMFORT (Felt diffuse chest pressure throughout the chest) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment information was not provided.   This case was linked to MOD-2021-293700 (Patient Link).
Late second dose of Havrix; Havrix pediatric administered to the adult patient; Havrix pediatric administered to the adult patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 46-year-old female patient who received HAV (Havrix pediatric) (batch number F3Y25, expiry date 15-FEB-2025) for prophylaxis.   Previously administered products included Hepatitis A vaccine (1st dose received on 29th March 2016).   On 08-JUN-2023, the patient received the 2nd dose of Havrix pediatric. On 08-JUN-2023, an unknown time after receiving Havrix pediatric, the patient experienced drug dose administration interval too long (Verbatim: Late second dose of Havrix), underdose (Verbatim: Havrix pediatric administered to the adult patient) and adult use of a child product (Verbatim: Havrix pediatric administered to the adult patient). The outcome of the drug dose administration interval too long, underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 15-JUN-2023 The reporter reported that the patient received late dose of Hepatitis A vaccine. The patient stated that it was unknown if the first dose was Havrix vaccine or other Hepatitis A vaccine. The vaccine administration facility was the same as primary reporter. The patient received 2nd dose of Havrix late than recommended time frame, which led to lengthening of vaccination schedule. The adult patient by mistakenly administered a pediatric dose of Havrix , which led to underdose and adult use of a child product. The reporter did consent to follow up. The case US2023084478 is identified as duplicate of case US2023084480. All future correspondence would be added in case US2023084480, which stands as case of record for this patient and the case US2023084478 would be deleted.
Fever, chills lasting 36 hours, brain fog ongoing, inability to focus ongoing, fatigue ongoing
faint along; abnormally sore arm; This spontaneous report was received from a Pfizer Inc, regarding a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, concomitant therapies, previous drug reactions, or allergies were not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (doses, frequencies, vaccination schemes, anatomical locations, lot number or expiration dates were not provided) for prophylaxis.  On an unknown date, the patient stated that when she got the polio vaccine, she had not side effects, but, when she got the second and third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) faint along with having an abnormally sore arm. The covid vaccine (manufacturer unknown) made her have brain fog like her first pregnancy, along with being completely down/ill for one week, and a horribly sore arm/hand for nearly a year. She was not of age to receive varicella zoster vaccine rge (cho) (SHINGRIX), but she had heard countless stories from that age group of how they were ill for some time and completely down for two days. The outcome of the events syncope and pain in extremity was not provided.  The causality assessment between the events syncope and pain in extremity with the suspect vaccines was not reported.   Upon internal review, the event syncope was determined to be medically significant.
Pains everywhere; Ear pain; Back pain; Joint pain; Headaches; Fever of 100 to 101 degree Farenheight; This spontaneous case was reported by a consumer and describes the occurrence of PAIN, EAR PAIN, BACK PAIN, ARTHRALGIA, and HEADACHE in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in September 2021.    On 09-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Nov-2021, the patient experienced PAIN, EAR PAIN, BACK PAIN, ARTHRALGIA, HEADACHE, and PYREXIA. At the time of the report, PAIN, EAR PAIN, BACK PAIN, ARTHRALGIA, HEADACHE and PYREXIA outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on 10-Nov-2021, Body temperature 100 to 101 degrees farenheight.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were Reported.  Patient felt like Covid-19 again.  No Treatments were reported.
Fever Body ache. sore. chiLLs. fever 99.4 Narrative:
Skin reaction; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old female patient received BNT162b2 (BNT162B2), on 21Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 77 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Highly allergic to antibiotics " (unspecified if ongoing); "Has food allergies" (unspecified if ongoing); "Has a lot of allergies to medications" (unspecified if ongoing); "Has a lot of allergies to amongst other things / external allergies" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Sulfur, reaction(s): "Highly allergic". Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Right arm), administration date: 11Feb2021, when the patient was 76-year-old, for Covid-19 Immunization, reaction(s): "Skin reaction"; BNT162b2 (DOSE 2, SINGLE, Right arm), administration date: 10Mar2021, when the patient was 76-year-old, for Covid-19 Immunization, reaction(s): "Skin reaction". The following information was reported: SKIN REACTION (non-serious) with onset 2021, outcome "recovered" (2023). The event "skin reaction" required physician office visit. Therapeutic measures were taken as a result of skin reaction.  Additional information: The patient did not receive any other vaccines within 4 weeks prior vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Vaccine administered was outdated when given. Expiration date was 7/2/12 and the injection was given 7/5/12.
hydrochloride (ALLEGRA) from on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 12:00, the patient had experienced fatigue, nausea, fever, soreness and headache. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fatigue, nausea, fever, soreness and headache was resolved on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
I gave the second dose of Hepatitis A too early. Patient received the first dose 5/1/2023 and wasn't due until 6 months later in November.
Narrative:  Patient reports possible signs and symptoms since injection of"pain in my legs since i got the shot, especially when im walking and i think it could be a blood clot." This RN instructed him to notify his PC to schedule US to r/o blood clot. He has not yet notified them in the last month. This RN told him to go to ER for any significant symptoms for shortness of breath, swelling in extremities/heat at calf site. Patient states that he will tell his home health nurse on Monday to see about scheduling and US of extremities and that he will go to ER if he has worse symptoms between now and then. Patient instructed to monitor for the following symptoms over the course of three weeks after the vaccination. * A headache that occurs 6 days or more after vaccination * A headache that is different from other headaches you have had * Confusion or trouble thinking clearly * Visual changes, such as blurry vision * Weakness, numbness, or trouble moving one or more parts of your body of your body, trouble speaking or seizures * Tiny spots under the skin away from the area where you had the infection (this is a sign of low platelets) Patient instructed to contact their agency health care provider if one or more of these symptoms develop. If symptoms are severe, seek immediate medical attention at the closest emergency department or call 9-1-1
Immediately pain in injection site and continued pain since then (2 weeks so far) as well as shoulder ache for past 3 days.
hard to pick up my son with both hands; range of motion is completely messed up; not sleeping well,cannot find a position to sleep in; exhausted of having shoulder pain; extreme pain in our shoulders on the side where we got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (hard to pick up my son with both hands), MOBILITY DECREASED (range of motion is completely messed up), INSOMNIA (not sleeping well,cannot find a position to sleep in), ARTHRALGIA (exhausted of having shoulder pain) and VACCINATION SITE PAIN (extreme pain in our shoulders on the side where we got the vaccine) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 041B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced HYPOKINESIA (hard to pick up my son with both hands), MOBILITY DECREASED (range of motion is completely messed up), INSOMNIA (not sleeping well,cannot find a position to sleep in), ARTHRALGIA (exhausted of having shoulder pain) and VACCINATION SITE PAIN (extreme pain in our shoulders on the side where we got the vaccine). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and CYCLOBENZAPRINE for Adverse event, at a dose of Unknown. At the time of the report, HYPOKINESIA (hard to pick up my son with both hands), MOBILITY DECREASED (range of motion is completely messed up), INSOMNIA (not sleeping well,cannot find a position to sleep in), ARTHRALGIA (exhausted of having shoulder pain) and VACCINATION SITE PAIN (extreme pain in our shoulders on the side where we got the vaccine) outcome was unknown.            No concomitant medications were reported.  It has mentioned that the patient healthcare professional thought that the shoulder pain may be due to an injury during the administration of the vaccine, got recommended physical therapy, using pain killers and taking sleeping pills for the symptoms.   This case was linked to MOD-2021-288027 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Aug-2021: Patient demographic details were added.
Injection site pain. Has had pain over injection site started day of vaccination until today (6/28/2022).
On January 12, 2021 at 2 pm, I received my first shot of the Pfizer vaccine. Approx. 19 hours later around 0930 on the the 13th of January, I was watching TV when I started loosing my vision in my right eye. In about 2 minutes my vision was completely gone in my right eye. I called 911 immediately and took an ambulance to the hospital.  Vision came back approx. 5 hours later but I have 5% vision loss in center of the eye-a permanent grey spot. I spent 2 days in the hospital for observation.
Information has been received from a nurse referring to a patient of unknown age and gender. Concomitant therapies included sterile diluent. Information about concurrent condition, drug reactions/allergies and medical history was not provided. On 05-SEP-2018, the patient received one dose of improperly stored (-9 Celsius (C) degree to 8 C degree for 68 minutes; previous temperature excursion: -9 C degree to 8 C degree for 76 minutes) PROQUAD (rHA, lot # R002931, expiration date 29-JUL-2019; strength and route were not reported) for prophylaxis; reconstituted with properly stored sterile diluent (as reported lot# M039639, expiration date 28-MAY-2019). No adverse effects reported. The reporter called because of a data logger. Sender's Comments: US-009507513-1809USA005628: US-009507513-1809USA011283: US-009507513-1809USA011743: US-009507513-1809USA011744: US-009507513-1809USA011745: US-009507513-1809USA011746: US-009507513-1809USA011747: US-009507513-1809USA011748: US-009507513-1809USA011750: US-009507513-1809USA011751: US-009507513-1809USA011752: US-009507513-1809USA011753: US-009507513-1809USA011754: US-009507513-1809USA011755: US-009507513-1809USA011756: US-009507513-1809USA011757: US-009507513-1809USA011758: US-009507513-1809USA011759.
Severe local reaction-(L) thigh swollen, mild diffuse erythema and tenderness
the shots hurt so much/ the arm stills hurts when they touch it; received 2 injections, one in each arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (the shots hurt so much/ the arm stills hurts when they touch it) and EXTRA DOSE ADMINISTERED (received 2 injections, one in each arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0T0M21A, 048A21A and 23M20DA) for COVID-19 vaccination.     Concurrent medical conditions included Chronic obstructive pulmonary disease and Chronic pain. Concomitant products included OXYGEN for Chronic obstructive pulmonary disease.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, the patient experienced VACCINATION SITE PAIN (the shots hurt so much/ the arm stills hurts when they touch it) and EXTRA DOSE ADMINISTERED (received 2 injections, one in each arm). On 20-Dec-2021, EXTRA DOSE ADMINISTERED (received 2 injections, one in each arm) had resolved. At the time of the report, VACCINATION SITE PAIN (the shots hurt so much/ the arm stills hurts when they touch it) had not resolved.            Patient stated that HCP told them it was a third round of the Moderna vaccine but the vaccination card does not state the type of dose they received. Concomitant medications included breathing medicine 3 to 4 times a day and pain medicine for chronic condition. It was reported that Oxygen was given all the time for  Chronic obstructive pulmonary disease. Patient also stated she takes around 16 medications. Treatment medications were not reported.
This spontaneous report as received from a physician refers to 29 patients of unknown demographics. On unknown dates, the patients received doses of improperly stored ROTATEQ (lot # M019691, expiry date: 02-NOV-2017). Excursion: 1.3C for 77 minutes cumulatively. Data logger was involved. No adverse effects reported. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
sinus pressure; headache; This spontaneous case was reported by a consumer and describes the occurrence of PARANASAL SINUS DISCOMFORT (sinus pressure) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PARANASAL SINUS DISCOMFORT (sinus pressure) and HEADACHE (headache). At the time of the report, PARANASAL SINUS DISCOMFORT (sinus pressure) and HEADACHE (headache) outcome was unknown.            Action taken with response to the drug is not applicable treatment information is not provided by the reporter No concomitant medication information was provided.
My 16 year old daughter got her second does of the Covid vaccine (Pfizer). She began having mild symptoms of acute appendicitis the next day. Symptoms gradually worsened over the next 3 days and on day 4 she was admitted to the hospital and is currently in surgery.
Next day following vaccine shot (Saturday), experienced fatigue, dizziness, nausea, hot flashes (about 4 episodes throughout the morning/ afternoon).  *Also developed blisters on toes that I thought were insect bites, however they are only on my toes - both feet.  Throughout the rest of Saturday they seemed to worsen.  Toes became more red -like sun burn, developed tingly, burning sensation.  Next day Sunday, they were more like blisters -clearly not insect bites.  Sensitive to the touch/ painful.  Toes felt swollen and uncomfortable - still had not spread.  Someone mentioned "Covid Toes" to me which I looked up online - this is almost exactly what I was experiencing, except not so much purple/ discoloration.  Blisters were skin colored.  I did an at home COVID test which was NEGATIVE.  Monday, a couple of the blisters did turn a darker purple...the burning, tingly sensation continues.  They are slightly itchy.  No other symptoms of illness at all since Saturday feeling unwell after shot.  Uncomfortable to wear shoes.   Today, is Tuesday and there is little to no change at this time.